Menu

A Common Path to Unconsciousness

Analyses of brain activity patterns show that different drugs induce anesthesia via a common neural mechanism.

May 22, 2013
Dan Cossins

KetamineWIKIMEDIA, PSYCHONAUTDiverse anesthetic drugs, each with distinct molecular targets, disrupt communication between the front and rear of the brain, according to a new study published today (May 22) in Anesthesiology. The findings provide the strongest evidence yet that inhibition of frontal-parietal connectivity may be the common mechanism by which all anesthetics induce loss of consciousness.

“If the study’s findings are confirmed by subsequent work, the paper will achieve landmark status,” wrote Jamie Sleigh of the University of Auckland, who was not involved in the study, in an accompanying commentary. “[It] not only sheds light on the phenomenon of general anesthesia, but also how it is necessary for certain regions of the brain to communicate accurately with one another for consciousness to emerge.”

Researchers already knew that the commonly used anesthetics sevoflurane and propofol break down this particular route of brain communication. But it was not clear if ketamine, which acts on different molecular targets, works in the same way. To find out, a team led by George Mashour of the University of Michigan, Ann Arbor, analyzed electroencephalogram (EEG) recordings from patients who received ketamine and compared the results to EEG data from a previous study of patients who received propofol and sevoflurane.

They found that although the raw EEGs looked very different, all three drugs caused a very similar inhibition of the passage of information between the front and rear of the brain. Analysis of frontal-parietal connectivity could therefore provide a universal metric of depth of anesthesia, which may lead to better anesthesia monitors that work reliably across all kinds of drugs. (For more on monitoring anesthesia, see our recent story “Measuring Consciousness.”)

The research also suggests that intact frontal-parietal communication is a prerequisite for consciousness, adding weight to the theory that consciousness relies on the integration of information between cortical regions of the brain.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.